ArticleProblemy endokrinologii2024
[Features of glycemic variability in men with different types of obesity].
Article in Problemy endokrinologii, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundObesity generally determines the metabolic basis for the development of type 2 diabetes. Therefore the analysis of glycemic variability in obese individuals, especially in its different phenotypes, acquires particular relevance.
aimTo investigate the features of glycemic variability in men with different adipose tissue distribution topography within usual dietary conditions. MATERIALS AND
methodsThe study enrolled 43 men aged 25-65 years. Group 1 (n=17) represented obese men with subcutaneous fat distribution (SFD) while group 2 (n=16) consisted of obese men with abdominal fat distribution (AFD) and group 3 (comparator) included 10 male subjects with normal body weight (NBW). A 2-day continuous glucose monitoring (CGM) under condition of usual diet, work and physical activity was performed in each study subject. A number of parameters, indices and ratios had been assessed describing glycemic variability (GV) for daytime (6.00-23.59) and night (0.00-5.59) hours.
resultsComparative analysis of key parameters and indices describing daytime and night GV in NBW and obese men without fat distribution adjustment did not reveal statistically significant differences. After fat distribution adjustment significantly higher mean glucose levels, standard deviation of glycemic levels and coefficient of variation were found in AFD group; also statistically significant differences were revealed in CONGA index and J-index. An analysis of the LBGI and HBGI indices that are respectively reflecting the risks of hypo- and hyperglycemia showed that the LBGI index was higher in obese men with SFD while the НBGI index was higher in men with AFD. A comparative analysis of GV parameters showed that daytime indicators values were significantly higher relative to nighttime. However the ambiguous changes in the mean glucose levels was found between study groups. Specifically in NBW men daytime and nighttime glycemia didn't differ, whereas in AFD group there was a trend to decrease in night glucose levels (p = 0.08) while in men with SFD night decrease in glycemia became statistically significant (p=0.005).
conclusionResults of glycemic variability assessment in obese men suggest that abdominal and subcutaneous types of fat distribution are associated with specific features of carbohydrate metabolism and determine different risk levels for developing type 2 diabetes in patients with AFD and SFD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.